{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', 'e 2008 Research Foundation for Mental Hygiene, Inc.', \"C-SSRS-Children's Baseline/Screening (Version 6/23/10)\", 'Page 1 of 2', '237']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', '238']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', \"Children's Since Last Visit\", 'COLUMBIA-SUICIDE SEVERITY', 'RATING SCALE', '(C-SSRS)', \"Children's Since Last Visit\", 'Version 6/23/10', 'Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.;', 'Burke, A.; Oquendo, M.; Mann, J.', 'Disclaimer:', 'This scale is intended to be used by individuals who have received training in its administration. The questions contained', 'in the Columbia-Suicide Severity Rating Scale are suggested probes. Ultimately, the determination of the presence of', 'suicidal ideation or behavior depends on the judgment of the individual administering the scale.', 'Definitions of behavioral suicidal events in this scale are based on those used in The Columbia Suicide History', 'Form, developed by John Mann, MD and Maria Oquendo, MD, Conte Center for the Neuroscience of Mental Disorders', '(CCNMD), New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032. (Oquendo M. A.,', 'Halberstam B. & Mann J. J., Risk factors for suicidal behavior: utility and limitations of research instruments. In M.B. First', '[Ed.] Standardized Evaluation in Clinical Practice, pp. 103 - 130, 2003.)', 'For reprints of the C-SSRS contact Kelly Posner, Ph.D., New York State Psychiatric Institute, 1051 Riverside Drive, New', 'York, New York, 10032; inquiries and training requirements contact posnerk@nyspi.columbia.edu', 'C 2008 The Research Foundation for Mental Hygiene, Inc.', '239']\n\n###\n\n", "completion": "END"}